Japan · 
What does DBJ Capital invest in?
DBJ Capital invests most often at Venture and Series A (70% of the rounds on record), in sectors such as Connected-health, Biopharma and Healthier Living.
DBJ Capital highlights
- 01
7 cheques in the last 12 months
- 02
Mostly Venture and Series A: 70% of its rounds
- 03
Sole investor in 8 rounds, median $5.2M
What they do
DBJ Capital is a venture capital firm that is 100% owned by Development Bank of Japan Inc. (DBJ).Translated from Japanese, from their own website
- Type
- Government (from a list, unverified)
- Cheque size
- Not stated
- Stages
- SeedSeries ASeries BGrowthPre-IPO
- Sectors
- Connected-healthBiopharmaHealthier Living
- Based in
- Chiyoda, Japan
- Cold pitches
- Not stated
The record
Every round we can evidence, newest first56 appearances
- 2026
5 rounds
- Oct
- Jun
- Apr
- Mar
- Feb
- 2025
8 rounds
- Nov
- Nov
- Oct
- Oct
- Aug
- Mar
- Mar
- Jan
- 2024
10 rounds
- Dec
- Nov
- Oct
- Sept
- Sept
- Sept
- Aug
- May
- May
- Apr
- 2023
2 rounds
- Jun
- Jan
- 2022
2 rounds
- Sept
- Aug
- 2021
4 rounds
- Sept
- Jul
- Jul
- May
- 2020
9 rounds
- Dec
- Dec
- Sept
- Sept
- Jul
- Jun
- May
- Apr
- Jan
An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.
The team
We hold 2 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.
What they claim to have backed
From their own portfolio page (on their website)
41 of 60 we have independently watched raise
ClipLine㈱Contrea㈱EX4Energy㈱FastLabel㈱GVA TECH㈱Hmcomm㈱MyDearest㈱Non Brokers㈱PlusoneRecustomer㈱Xenodata-labforest㈱ウェルスナビ㈱クレアトゥラ㈱㈱Alivas㈱Arrowsmith㈱DigitalArchi㈱Facilo㈱Ginco㈱Holoway㈱JCG㈱JTOWER㈱KAKEAI㈱KURASERU㈱LEAN BODY㈱LexxPluss㈱Looop㈱MaaS Tech Japan㈱NearMe㈱PRISM BioLab㈱SHONAI㈱Shippio㈱Sprocket㈱TL Genomics㈱Timers㈱WAKAZE㈱mediVR㈱meleap㈱スマートバンク㈱パワーレーザー京都フュージョニアリング㈱Acall㈱CYBERDYNE㈱G-FACTORY㈱GiasuGitaiHISHOH Biopharma㈱MOSH㈱Meltly㈱REVISIO㈱SOZOW㈱TOPICO㈱UPWARD㈱へパリスファーマ㈱アドイノベーション㈱アリヴェクシス㈱エルピクセル㈱カプセルジャパン㈱カルナバイオサイエンス㈱クリングルファーマ㈱and 79 more
Weaker than a round we watched, stronger than a list somebody sold us. A firm is far less willing to put a company on its own site that it never funded.